Literature DB >> 5441881

Bile salt secretion in cirrhosis of the liver.

L A Turnberg, G Grahame.   

Abstract

Secretion of bile salts into the duodenum was studied in eight normal subjects, in 10 patients with cirrhosis, and in two cholecystectomized subjects. Duodenal juice was aspirated continuously through a double-lumen tube during an unstimulated period, after an intravenous injection of pancreozymin/cholecystokinin, and during a continuous intravenous infusion of secretin given at a rate of 3 units per kilogram body weight per hour. Precautions were taken to try to ensure quantitative recovery during the studies, and recovery of an infused nonabsorbable marker was greater than 80% in all subjects. Secretin induced a flow of a greater volume of juice in the cirrhotic patients than in the normal group (49 to 57 ml per 10 minutes compared with 28 to 49 ml per 10 minutes). This change may have resulted from a higher effective dose of secretin if it is assumed that the cirrhotic liver fails to catabolize secretin. The bile acid response to pancreozymin/cholecystokinin followed by secretin in the cirrhotic subjects resembled that seen in patients after cholecystectomy in whom pancreozymin/cholecystokinin induces only a slight increase in bile salt output but in whom the output of bile salts during rest and secretin stimulation is markedly greater than normal. This response in cirrhosis is probably best interpreted as due to impaired function of the gallbladder. The total amount of bile salt liberated over the two hours of the test in the cirrhotic patients was similar to normal The concentration of bile salt after pancreozymin/cholecystokinin was less than in normal subjects, but similar to that in cholecystectomized patients. It is unlikely therefore that deficient output or concentration of bile salt can be held responsible for steatorrhea in cirrhosis. THERE WAS A MARKED DECREASE IN THE DEOXYCHOLATE CONJUGATES AND A REDUCTION IN THE GLYCINE: taurine ratio in the bile of cirrhotic patients. The former change may reflect a change in bacterial flora and the latter a defect in hepatic conjugating mechanisms.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5441881      PMCID: PMC1411355          DOI: 10.1136/gut.11.2.126

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease.

Authors:  J B CAREY
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

3.  Cholecystography in portal cirrhosis without jaundice.

Authors:  C L CUNIFF; M A DOLAN; C M LEEVY
Journal:  Gastroenterology       Date:  1953-12       Impact factor: 22.682

4.  External pancreatic function in primary parenchymatous hepatic disease as measured by analysis of duodenal contents before and after stimulation with secretin.

Authors:  J B GROSS; M W COMFORT; E E WOLLAEGER; M H POWER
Journal:  Gastroenterology       Date:  1950-09       Impact factor: 22.682

5.  Total solids, fat and nitrogen in the feces: V. A study of patients with primary parenchymatous hepatic disease.

Authors:  J B GROSS; M W COMFORT; E E WOLLAEGER; M H POWER
Journal:  Gastroenterology       Date:  1950-09       Impact factor: 22.682

6.  The quantitative determination of bile salts in bile using thin-layer chromatography and 3 alpha-hydroxysteroid dehydrogenase.

Authors:  L A Turnberg; A Anthony-Mote
Journal:  Clin Chim Acta       Date:  1969-05       Impact factor: 3.786

7.  Two sites of bile formation as determined by mannitol and erythritol clearance in the guinea pig.

Authors:  E L Forker
Journal:  J Clin Invest       Date:  1967-07       Impact factor: 14.808

8.  The metabolism of intravenously injected isotopic cholic acid in Laennec's cirrhosis.

Authors:  M Blum; N Spritz
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

9.  The metabolism of bile acids with special reference to liver injury.

Authors:  J B Carey; I D Wilson; F G Zaki; R F Hanson
Journal:  Medicine (Baltimore)       Date:  1966-11       Impact factor: 1.889

10.  On the conjugation and formation of bile acids in the human liver. VI. On the conjugation of cholic acid -2414C in human liver homogenates in various diseases with special reference to patients with jaundice; bile acids and steroids 66.

Authors:  P H EKDAHL
Journal:  Acta Chir Scand       Date:  1958
View more
  15 in total

1.  Aspects of bile acid metabolism in cystic fibrosis.

Authors:  M C Goodchild; G M Murphy; A M Howell; S A Nutter; C M Anderson
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

2.  Secretion of water and electrolytes into the duodenum in normal subjects and in patients with cirrhosis: the response to secretin and pancreozymin.

Authors:  L A Turnberg; G Grahame
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

3.  Absorption of vitamin E in children with biliary obstruction.

Authors:  J T Harries; D P Muller
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

4.  Effect of cholecystokinin-Pancreozymin on bile salt secretion into the duodenal juice in patients with liver cirrhosis.

Authors:  C Bode; H Goebell; W Kehl
Journal:  Klin Wochenschr       Date:  1971-08-01

5.  Relative concentrations of individual nonsulfated bile acids in the serum and bile of patients with cirrhosis.

Authors:  J E Struthers; S J Mehta; M D Kaye; J L Naylor
Journal:  Am J Dig Dis       Date:  1977-10

6.  Biliary squalene levels in hepatobiliary disease.

Authors:  Y Nosaka; Y Yamanishi; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1985-08

7.  The effect of cholecystectomy on bile salt metabolism.

Authors:  E W Pomare; K W Heaton
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

8.  Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.

Authors:  Y A Kesäniemi; T A Miettinen; M P Salaspuro
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

9.  Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease.

Authors:  T A Miettinen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

10.  Cholic acid synthesis as an index of the severity of liver disease in man.

Authors:  W C McCormick; C C Bell; L Swell; Z R Vlahcevic
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.